Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.316
-0.034 (-2.50%)
Nov 5, 2024, 1:03 PM EST - Market open
Kairos Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -2.01 | -1.81 | -1.05 | -2.15 |
| Depreciation & Amortization | 0.16 | 0.16 | 0.16 | 0.1 |
| Other Amortization | 0.08 | 0.06 | 0.41 | 0.14 |
| Stock-Based Compensation | - | - | - | 0.3 |
| Other Operating Activities | 0.91 | 0.91 | - | - |
| Change in Accounts Payable | 0.87 | 0.77 | 0.13 | 1.19 |
| Change in Other Net Operating Assets | 0.01 | -0.01 | - | - |
| Operating Cash Flow | 0.03 | 0.08 | -0.35 | -0.41 |
| Cash Acquisitions | - | - | - | -0.11 |
| Investing Cash Flow | - | - | - | -0.11 |
| Long-Term Debt Issued | - | - | 0.93 | 0.35 |
| Short-Term Debt Repaid | - | - | -0.04 | -0.02 |
| Total Debt Repaid | - | - | -0.04 | -0.02 |
| Net Debt Issued (Repaid) | 0.1 | - | 0.89 | 0.33 |
| Issuance of Common Stock | - | - | - | 0.25 |
| Other Financing Activities | -0.34 | -0.43 | -0.17 | - |
| Financing Cash Flow | -0.24 | -0.43 | 0.72 | 0.58 |
| Net Cash Flow | -0.21 | -0.34 | 0.36 | 0.06 |
| Free Cash Flow | 0.03 | 0.08 | -0.35 | -0.41 |
| Free Cash Flow Per Share | 0.00 | 0.01 | -0.03 | -0.05 |
| Levered Free Cash Flow | -0.04 | -0.15 | 0.01 | - |
| Unlevered Free Cash Flow | -0.04 | -0.15 | -0.12 | - |
| Change in Net Working Capital | -0.98 | -0.76 | -0.08 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.